HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Adrien Contejean Selected Research
Adrien Contejean Research Topics
Disease
4
COVID-19
05/2022 - 01/2021
2
Infections
01/2022 - 01/2022
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 01/2019
2
Philadelphia Chromosome
12/2021 - 01/2019
2
Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2021
2
Agranulocytosis (Granulocytopenia)
01/2020 - 01/2020
2
Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 12/2016
2
Aplastic Anemia (Anemia, Hypoplastic)
01/2019 - 01/2019
1
Herpes Zoster
01/2022
1
Febrile Neutropenia
01/2022
1
Leukemia
01/2022
1
Human Influenza (Influenza)
01/2022
1
Myeloid Sarcoma (Chloroma)
11/2021
1
Neoplasms (Cancer)
11/2021
1
Arthritis (Polyarthritis)
01/2021
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1
Multiple Myeloma
07/2020
1
Hairy Cell Leukemia
01/2020
1
Melanoma (Melanoma, Malignant)
01/2020
1
Systemic Mastocytosis
01/2020
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2019
1
Respiratory Insufficiency (Respiratory Failure)
12/2016
1
Invasive Pulmonary Aspergillosis
12/2016
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2016
Drug/Important Bio-Agent (IBA)
2
Pharmaceutical Preparations
IBA
01/2022 - 01/2020
2
Piperacillin
FDA Link
Generic
01/2021 - 01/2021
2
Vemurafenib
IBA
01/2020 - 01/2020
1
Vaccines
IBA
05/2022
1
ChAdOx1 nCoV-19
IBA
05/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Levofloxacin (Levaquin)
FDA Link
01/2022
1
COVID-19 Vaccines
IBA
01/2022
1
BNT162 Vaccine
IBA
01/2022
1
2019-nCoV Vaccine mRNA-1273
IBA
01/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022
1
ponatinib
IBA
12/2021
1
asciminib
IBA
12/2021
1
nelarabine (506U78)
FDA Link
11/2021
1
venetoclax
IBA
11/2021
1
Monoclonal Antibodies
IBA
01/2021
1
Meropenem (Merrem)
FDA Link
Generic
01/2021
1
Cefepime (Maxipime)
FDA Link
Generic
01/2021
1
Vancomycin
FDA Link
Generic
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
miltefosine (Impavido)
IBA
01/2021
1
Teicoplanin
IBA
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Immunoglobulin G (IgG)
IBA
07/2020
1
Proto-Oncogene Proteins B-raf
IBA
01/2020
1
Tryptases (Tryptase)
IBA
01/2020
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2019
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2019
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2019
1
romiplostim
FDA Link
01/2019
1
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2019
1
Steroids
IBA
01/2019
1
hydroxide ion
IBA
12/2016
1
Brentuximab Vedotin
IBA
03/2016
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
01/2022 - 01/2019
1
Therapeutics
01/2021
1
Personal Protective Equipment
01/2021
1
Hematopoietic Stem Cell Transplantation
01/2019
1
Artificial Respiration (Mechanical Ventilation)
12/2016